Vantia Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vantia Limited.The latest application filed is for "new polymorph".

Company Profile

0.8.5

Vantia Limited - Southampton GB
Vantia Limited - Chilworth GB
Vantia Limited - GB GB
Vantia, Ltd -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline-N, N-dimethylamide Grant 9,145,397 - Peal September 29, 2	2015-09-29
Polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamo- yl)-L-proline-N,N-dimethylamide Grant 9,079,881 - Johan , et al. July 14, 2	2015-07-14
Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4, 10-dihydro-3H-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamid- e Grant 9,073,928 - Batt , et al. July 7, 2	2015-07-07
New Polymorph App 20140296213 - Johan; Kjellstrom Henrik ; et al.	2014-10-02
Process For The Preparation Of 1 - (2-methyl-4- (2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) Benzylcarbamoyl) - L - Proline - N, N-dimethylamide App 20140066619 - Peal; Valerie Elizabeth	2014-03-06
Vasopressin V.sub.1a antagonists Grant 8,202,858 - Batt , et al. June 19, 2	2012-06-19
FAP inhibitors Grant 8,183,280 - Evans , et al. May 22, 2	2012-05-22
1,4-disubstituted Piperidines As Vasopressin Receptor Via Antagonists App 20110312941 - Batt; Andrzej Roman ; et al.	2011-12-22
Heterocyclic condensed compounds useful as antidiuretic agents Grant 8,063,038 - Pitt November 22, 2	2011-11-22
Aminopyridine Derivatives App 20100076015 - Evans; David Michael ; et al.	2010-03-25
Selective dipeptide inhibitors of kallikrein Grant 7,649,000 - Evans January 19, 2	2010-01-19
Condensed azepines as vasopressin agonists Grant 7,560,454 - Ashworth , et al. July 14, 2	2009-07-14
Non-peptide GnRH antagonists App 20080255109 - Roe; Michael Bryan ; et al.	2008-10-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.